Tatsuro Misu

10PUBLICATIONS
63CO-AUTHORS
Clinical pharmacology and therapeuticsMedical infection agents (incl. prions)Neurology and neuromuscular diseasesRheumatology and arthritisAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 24, 2026
Real-World Treatment Adherence and Persistence with C5 Inhibitor Therapy Versus Satralizumab in Patients with Neuromyelitis Optica Spectrum Disorder in Japan.

|Feb 20, 2026
Outcome Predictors in Progressive Multifocal Leukoencephalopathy Associated With Multiple Sclerosis Treatments: A Multicenter Cohort Study.

Julie Céline Blant, Nicola De Rossi, Ralf Gold

|Feb 11, 2026
Complement Inhibition for Acute Neuromyelitis Optica Spectrum Disorder Attacks: Insights From an International Case Series.

Paulus S Rommer, Wei Jiang, Jan P Nolte

|Jan 28, 2026
Changes in Blood Cells and Complements During Relapse Prevention Therapies for Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder.

Hiroshi Kuroda, Kazuo Fujihara, Kimihiko Kaneko

|Sep 13, 2025
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Pathophysiology, Clinical Patterns, and Therapeutic Challenges of Intractable and Severe Forms.

Tatsuro Misu

|May 07, 2025
CD4-Positive T-Cell Responses to MOG Peptides in MOG Antibody-Associated Disease.

Hirohiko Ono, Tatsuro Misu, Chihiro Namatame

Pageof 2

Frequent Collaborators

3 joint publications

Kazuo Fujihara

3 joint publications

Ichiro Nakashima

2 joint publications

Ralf Gold

2 joint publications

Aude Maurousset